We have located links that may give you full text access.
Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus.
Journal of Refractive Surgery 2009 September
PURPOSE: Retrospective evaluation of haze development after riboflavin-ultraviolet (UV) A-induced corneal collagen cross-linking (CXL).
METHODS: One hundred sixty-three eyes of 127 patients with stage 1-3 keratoconus according to Krumeich's classification were included in this retrospective analysis. Follow-up was 1 year. Preoperatively and at all follow-up examinations uncorrected visual acuity, best spectacle-corrected visual acuity (BSCVA), slit-lamp microscopic findings, corneal topography, and corneal thickness were recorded.
RESULTS: At 1 year after CXL, 149 (91.4%) eyes of 114 patients had a clear cornea without stromal haze (control group), whereas 14 eyes (8.6%) of 13 patients developed clinically significant stromal haze (haze group). Preoperatively, the mean keratometry (K) value of the apex was 62.1+/-13.8 diopters (D) in the control group and 71.1+/-13.2 D in the haze group (P=.02). The mean corneal thickness before the procedure was 478.1+/-52.4 mum in the control group and 420.0+/-33.9 mum in the haze group (P=.001). Uncorrected visual acuity and BSCVA, which were similar between groups preoperatively (P=.59 and P=.75, respectively), were improved in the control group (P=.023 and P=.001, respectively), but reduced in the haze group (P=.012 and P=.004, respectively) postoperatively.
CONCLUSIONS: The parameters defining the stage of keratoconus, such as K-value and corneal thickness, could be considered predicting factors for possible development of corneal haze after riboflavin-UVA-induced CXL. Advanced keratoconus should be considered at higher risk of haze development after CXL due to low corneal thickness and high corneal curvature.
METHODS: One hundred sixty-three eyes of 127 patients with stage 1-3 keratoconus according to Krumeich's classification were included in this retrospective analysis. Follow-up was 1 year. Preoperatively and at all follow-up examinations uncorrected visual acuity, best spectacle-corrected visual acuity (BSCVA), slit-lamp microscopic findings, corneal topography, and corneal thickness were recorded.
RESULTS: At 1 year after CXL, 149 (91.4%) eyes of 114 patients had a clear cornea without stromal haze (control group), whereas 14 eyes (8.6%) of 13 patients developed clinically significant stromal haze (haze group). Preoperatively, the mean keratometry (K) value of the apex was 62.1+/-13.8 diopters (D) in the control group and 71.1+/-13.2 D in the haze group (P=.02). The mean corneal thickness before the procedure was 478.1+/-52.4 mum in the control group and 420.0+/-33.9 mum in the haze group (P=.001). Uncorrected visual acuity and BSCVA, which were similar between groups preoperatively (P=.59 and P=.75, respectively), were improved in the control group (P=.023 and P=.001, respectively), but reduced in the haze group (P=.012 and P=.004, respectively) postoperatively.
CONCLUSIONS: The parameters defining the stage of keratoconus, such as K-value and corneal thickness, could be considered predicting factors for possible development of corneal haze after riboflavin-UVA-induced CXL. Advanced keratoconus should be considered at higher risk of haze development after CXL due to low corneal thickness and high corneal curvature.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app